SceneRay

景昱医疗科技(苏州)股份有限公司

SceneRay was founded in 2011, is headquartered in Suzhou, China, lists 201–500 employees, and has 1 recorded funding round.

Headquarters
Suzhou, Jiangsu
Employees
201–500
Founded
2011
Business Model
B2B
Rounds
1

Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.

About

SceneRay is an innovative high-tech medical device company headquartered in the Suzhou Industrial Park, China, dedicated to the research, development, production, and sales of deep brain stimulation (DBS) systems and brain-computer interface technology. Founded in 2011, the company focuses on Class III implantable active medical devices, specializing in DBS systems for Parkinson's disease and brain-computer interfaces for treating addictive mental illnesses such as opioid use disorder. SceneRay's proprietary Neurestora system received approval from China's National Medical Products Administration in December 2025 as the world's first DBS-based solution for treating moderate-to-severe opioid addiction. The company has also received FDA Breakthrough Device Designation for its dual-target DBS therapy and has conducted over 14 years of clinical research. Its team includes more than 200 experts and graduates from leading Chinese universities including Tsinghua and Peking University.

Summary

SceneRay is a Healthcare company based in Suzhou, China, founded in 2011. It lists 201–500 employees. Investors include GL Ventures, HongShan (Sequoia China) and Sequoia Capital.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

OtherVenture RoundFeb 2022
$44.6M

Sign up to see all 2 events

Funding, valuations, and company events, with amounts and investors where available.

Investors

Similar Companies

Neko Health

Neko Health delivers preventive health scans that combine skin, heart, blood, and body measuremen...

Stockholm, Sweden201–500Artificial Intelligence, Digital Health
Series CTotal funding$1.1BJul 2026
MultiPlanIPO

Healthcare cost management company providing data analytics and network-based payment solutions t...

New York, United States1001–5000Healthcare
Private EquityTotal funding$7.4BMar 2014
The Bountiful CompanyAcquired

American dietary supplements company owning Nature's Bounty, Solgar, and Puritan's Pride brands; ...

Ronkonkoma, United States1001–5000Healthcare, Retail
Private EquityTotal funding$7.0BJul 2017
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
OneOncologyAcquired

OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...

Nashville, United States1001–5000Healthcare, Data & Analytics
Extension RoundTotal funding$5.1BDec 2025
Canopy Growth Corporation Common SharesIPO

World-leading Canadian cannabis company cultivating and selling medicinal and recreational cannab...

Smiths Falls, Canada1001–5000Healthcare
Corporate RoundTotal funding$4.5BJan 2024

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

SceneRay on Indexed.vc
<a href="https://indexed.vc/companies/sceneray"><img src="https://indexed.vc/api/badge/company/sceneray" alt="SceneRay on Indexed.vc" width="260" height="76" /></a>